Biblio Discovery — Demo Discovery Service

6 hasil untuk "Robbert G.M. Bredius"

Menampilkan 1–6 · 1,98 detik · RSS

  1. Artikel Jurnal Teks lengkap

    Introducing Newborn Screening for Severe Combined Immunodeficiency (SCID) in the Dutch Neonatal Screening Program

    Maartje Blom; Robbert G.M. Bredius; Gert Weijman dkk.

    International Journal of Neonatal Screening, Vol. 4 No. 4 · 2018 · Inggris · DOAJ Scopus

    The implementation of newborn screening for severe combined immunodeficiency (SCID) in the Netherlands is a multifaceted process in which several parties are involved. The Dutch Ministry of Health adopted the advice of the Dutch Health Council to include SCID in the Dutch newborn screening program…

  2. Artikel Jurnal

    Proceeding of the European Group for Blood and Marrow Transplantation (EBMT) congress on sickle cell disease, 16–17 may 2019, Regensburg, Germany What is the impact of antithymocyte globulin pharmacokinetics on haploidentical hematopoietic stem cell transplantation?

    Lisa V.E. Oostenbrink; Cornelia M. Jol-van der Zijde; Anja M. Jansen-Hoogendijk dkk.

    Hematology/Oncology and Stem Cell Therapy, Vol. 13 No. 2 · 2020 · Inggris · DOAJ Scopus

    Antithymocyte globulin (ATG) is a widely accepted part of the conditioning regimen applied in the setting of hematopoietic stem cell transplantation (HSCT) to prevent graft rejection and graft-versus-host disease. Although weight-based dosing of ATG has been introduced to optimize ATG dosing…

  3. Artikel Jurnal

    Anti-T-lymphocyte globulin exposure is associated with acute graft-versus-host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: a multinational prospective study

    Lisa V.E. Oostenbrink; Erik G.J. von Asmuth; Cornelia M. Jol-van der Zijde dkk.

    Haematologica, Vol. 999 No. 1 · 2024 · Inggris · DOAJ Scopus

    Anti T-lymphocyte globulin (ATLG) is used in hematopoietic stem cell transplantation (HSCT) to prevent graft-versus-host disease (GvHD) and graft failure. To date, insight in ATLG pharmacokinetics and -dynamics (PK/PD) is limited, and population PK (POPPK) models are lacking. In this prospective…

  4. Artikel Jurnal Teks lengkap

    Second-tier genetics improves newborn screening accuracy for SCID and other T cell deficienciesSecond-tier genetics in TREC-based NBS

    Annelotte J. Duintjer; Maartje Blom; Robbert G.M. Bredius dkk.

    Journal of Human Immunity, Vol. 2 No. 5 · 2026 · Inggris · DOAJ Scopus

    This study demonstrates that second-tier genetics improves newborn screening accuracy for SCID and other T cell deficiencies. A safety net algorithm maintains high sensitivity for SCID while substantially increasing the PPV from 22.1% to 55.2%.

  5. Artikel Jurnal Teks lengkap

    Managing non-SCID T cell lymphopenia after TREC-based newborn screeningNon-SCID T cell lymphopenia after TREC-based NBS

    Annelotte J. Duintjer; Robbert G.M. Bredius; J. Merlijn van den Berg dkk.

    Journal of Human Immunity, Vol. 2 No. 2 · 2026 · Inggris · DOAJ Scopus

    TREC-based NBS detects many secondary findings and additional causes for T cell lymphopenia other than SCID. The clinical follow-up of these newborns poses a new challenge for pediatric immunologists. We present clinical follow-up data of 6.5 years of NBS for SCID, underscoring the importance of…